Vivid Dx
PrivateLast Round
Seed
Jul 28, 2026
Total Funding Raised
$20.56M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vivid Dx is a health tech company that develops a precision diagnostic platform for the rapid detection of sepsis-causing pathogens and antimicrobial resistance using Raman spectroscopy and AI-driven analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivid Dx Comparables
Compare Vivid Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resistell AG | 88% | |
| Astek Diagnostics | 87% | |
| iFAST Diagnostics | 86% | |
Vivid Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 28, 2026 | ||||
| Grant | Apr 1, 2025 | ||||
| Early Funding | Apr 1, 2024 | ||||
| Grant | Dec 1, 2023 | ||||
| Grant | May 1, 2023 |
Vivid Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Seed, Early Funding |
| JIMCO | Seed |
| Innovate UK | Grant |
| Cedars-Sinai Intellectual Property Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
$15M round led by Cedars-Sinai and Oxford Science Enterprises.
- Apr 20, 2026
Monthly visitors grew 75% MoM, reaching 2.4K.
Vivid Dx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivid Dx's valuation, stock price, and market status.